FINEORG vs TATVA: Stock Comparison

Fine Organic Industries Limited vs Tatva Chintan Pharma Chem Limited

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Fine Organic Industries Limited is the larger company by market capitalisation. Fine Organic Industries Limited shows a lower P/E, a higher ROE and a higher dividend yield, while Tatva Chintan Pharma Chem Limited shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Fine Organic Industries Limited and Tatva Chintan Pharma Chem Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, FINEORG is more favourable on 8 of 13 scored metrics and TATVA on 5These counts are context-free and are not an overall rating.

Key Differences

Market Cap
FINEORG is the larger company
₹14,618 Cr vs ₹4,000 Cr
P/E Ratio
FINEORG has a lower P/E
35.36x vs 78.97x
P/B Ratio
TATVA has a lower P/B
5.19x vs 5.53x
EPS
FINEORG has higher earnings per share
₹136.16 vs ₹18.84
Dividend Yield
FINEORG has a higher dividend yield
0.23% vs 0.08%
Revenue Growth (TTM YoY)
TATVA has faster revenue growth
24.4% vs 2.4%
EPS Growth (TTM YoY)
TATVA has faster EPS growth
907.5% vs 21%
Qtr Sales Growth
TATVA has stronger quarterly sales growth
24.4% vs 3.05%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricFINEORGTATVA
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricFINEORGTATVA
Live Price₹4,790.5₹1,718.2
Day Change-0.99%-4.55%
Volume6,1722.02 L
52-Week High₹5,407₹1,835
52-Week Low₹3,856₹976.4
Distance from 52W High-11.4%-6.37%

Valuation

MetricFINEORGTATVA
Market Cap₹14,618 Cr₹4,000 Cr
P/E Ratio35.36x78.97x
P/B Ratio5.53x5.19x
EPS₹136.16₹18.84
Book Value₹869.06₹334.03
Dividend Yield0.23%0.08%

Growth

MetricFINEORGTATVA
Revenue Growth (TTM YoY)2.4%24.4%
EPS Growth (TTM YoY)21%907.5%
Qtr Sales Growth3.05%24.4%
Qtr Profit Growth21%902%

Profitability & Leverage

MetricFINEORGTATVA
ROE16.6%5.53%
ROCE21.5%7.14%
Net Margin17.63%8.31%
Operating Margin20.3%11.13%
Debt to Equity0.03x15.4x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricFINEORGTATVA
Promoter Holding74.6%72.02%
FII Holding4.28% 0.12 pp3.93% 0.11 pp
DII Holding11.72% 0.07 pp3.11% 0.12 pp
Public Holding9% 0.05 pp20.94% 0.23 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Fine Organic Industries Limited and Tatva Chintan Pharma Chem Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.